# US 2020/0370036 A1 · Methods for Lysis of Cells Within a Sample

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0370036 A1
- Document ID: US20200370036A1
- Status: Published application
- Kind: A1
- Application number: 16/636,259
- Filed: 2018-08-03
- Published: 2020-11-26
- Earliest claimed: 2017-08-04
- Assignees: MicrobeDX Inc.; The Regents of the University of California
- Applicants: MicrobeDX, Inc.; The Regents of the University of California
- Inventors: Gabriel MONTI; Colin Wynn HALFORD; Alexandra PEREBIKOVSKY; Yujia LIU; Horacio KIDO; David Arnold HAAKE; Marc MADOU; Daniel GUSSIN; Bernard CHURCHILL
- Web page: https://patentgrep.com/patent/US20200370036A1

## CPC

- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12N 9/2462: {Lysozyme (3.2.1.17)}
- C12N 9/6489: {Metalloendopeptidases (3.4.24)}
- C12N 2500/12: Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12Y 302/01017: Lysozyme (3.2.1.17)
- C12Y 304/24075: Lysostaphin (3.4.24.75)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

There is described a method for extracting a target chemical compound from a cellular material in a sample. The method comprising the steps of: subjecting the sample to mechanical lysis to cause disruption of a cellular membrane in the cellular material; contacting the sample with an alkaline material to produce a lysate composition comprising the target chemical compound; and recovering the lysate composition from the sample. There is also described a method for producing a lysate composition comprising RNA from a mammalian bodily fluid sample comprising a cellular material. There is also described a method for extracting a nucleic acid from a cellular material in a bodily fluid or an inoculant derived therefrom.

## Claims

### Claim 1

A method for extracting a target chemical compound from a cellular material in a sample, the method comprising the steps of:
(a) subjecting the sample to mechanical lysis to cause disruption of a cellular membrane in the cellular material;
(b) contacting the sample with an alkaline material to produce a lysate composition comprising the target chemical compound; and
(c) recovering the lysate composition from the sample.

### Claim 2 (depends on 1)

The method defined in claim 1, wherein the target chemical compound is a nucleic acid.

### Claim 3 (depends on 1)

The method defined in claim 1, wherein the target chemical compound is DNA.

### Claim 4 (depends on 1)

The method defined in claim 1, wherein the target chemical compound is RNA.

### Claim 5 (depends on 1)

The method defined in claim 1, wherein the target chemical compound is ribosomal RNA (rRNA).

### Claim 6 (depends on 5)

The method defined in claim 5, wherein the rRNA is pre-ribosomal RNA.

### Claim 7 (depends on 5)

The method defined in claim 5, wherein the rRNA is selected from the group consisting of 16S rRNA, 23S rRNA and any mixture thereof.

### Claim 8 (depends on 5)

The method defined in claim 5, wherein the rRNA is mature rRNA.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method defined in any one of claims 1-8, wherein Step (b) comprising contacting the cellular material in the sample with an alkaline liquid.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method defined in any one of claims 1-8, wherein Step (b) comprising contacting the cellular material in the sample with an alkaline solution.

### Claim 11 (depends on 10)

The method defined in claim 10, wherein the alkaline solution is a sodium hydroxide solution.

### Claim 12 (depends on 9, 10, 11)

The method defined in any one of claims 9-11, wherein the alkaline solution has a concentration of 10M or less.

### Claim 13 (depends on 9, 10, 11)

The method defined in any one of claims 9-11, wherein the alkaline solution has a concentration in the range of from 1M to 5M.

### Claim 14 (depends on 9, 10, 11)

The method defined in any one of claims 9-11, wherein the alkaline solution has a concentration in the range of from 1.5M to 3M.

### Claim 15 (depends on 9, 10, 11)

The method defined in any one of claims 9-11, wherein the alkaline solution has a concentration of 2M.

### Claim 16 (depends on 9, 10, 11)

The method defined in any one of claims 9-11, wherein the alkaline solution has a concentration of 3M.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The method defined in any one of claims 1-16, wherein the cellular material is an unknown cellular material.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method defined in any one of claims 1-17, wherein the cellular material comprises a microorganism.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method defined in any one of claims 1-17, wherein the cellular material comprises bacteria.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method defined in any one of claims 1-17, wherein the cellular material comprises prokaryotic cells.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method defined in any one of claims 1-17, wherein the cellular material comprises Gram-negative bacteria.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method defined in any one of claims 1-17, wherein the cellular material comprises Gram-positive bacteria.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method defined in any one of claims 1-17, wherein the cellular material comprises virally infected cells.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method defined in any one of claims 1-17, wherein the cellular material comprises fungus cells.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method defined in any one of claims 1-17, wherein the cellular material comprises yeast cells.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The method defined in any one of claims 1-25, wherein the sample comprises mammalian cellular material.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method defined in any one of claims 1-26, wherein the sample comprises human cellular material.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method defined in any one of claims 1-27, wherein the sample comprises a bodily fluid.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method defined in any one of claims 1-27, wherein the sample comprises an inoculant derived from a bodily fluid.

### Claim 30 (depends on 28, 29)

The method defined in claim 28 or 29, wherein the bodily fluid is selected from the group consisting of blood, urine, saliva, sweat, tears, mucus, breast milk, plasma, serum, synovial fluid, pleural fluid, lymph fluid, amniotic fluid, feces, cerebrospinal fluid and any mixture of two or more of these.

### Claim 31 (depends on 28, 29)

The method defined in claim 28 or 29, wherein the bodily fluid is urine or an inoculant derived therefrom.

### Claim 32 (depends on 28, 29)

The method defined in claim 28 or 29, wherein the bodily fluid is blood or an inoculant derived therefrom.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The method defined in any one of claims 1-32, wherein, after disruption of the cellular membrane in the cellular material, the sample is subjected to biological lysis.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The method defined in any one of claims 1-32, wherein, after disruption of the cellular membrane in the cellular material, the sample is contacted with an enzyme.

### Claim 35 (depends on 34)

The method defined in claim 34, wherein the enzyme is selected from the group consisting of lysozyme, lysostaphin and any mixture thereof.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The method defined in any one of claims 1-32, wherein, after disruption of the cellular membrane in the cellular material, the sample is subjected to physical lysis.

### Claim 37 (depends on 36)

The method defined in claim 36, wherein the physical lysis is selected from the group consisting of heating, osmotic shock, cavitation or any combination of two or more of these.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of 10 minutes or less.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of from 30 seconds to 10 minutes.

### Claim 40 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of from 1 minute to 8 minutes.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of from 2 minutes±30 seconds.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of from 3 minutes±30 seconds.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of from 4 minutes±30 seconds.

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of from 5 minutes±30 seconds.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of from 6 minutes±30 seconds.

### Claim 46 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method defined in any one of claims 1-37, wherein Step (a) is conducted for a period of from 7 minutes±30 seconds.

### Claim 47 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis is selected from the group consisting of French press, shaking, grinding, bead beating, centrifugation and any combination of two or more of these.

### Claim 48 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis comprises bead beating.

### Claim 49 (depends on 48)

The method defined in claim 48, wherein bead beating comprises beating with ceramic beads, glass beads, zirconium beads, silica-zirconium beads, steel beads or any combination of two or more of these.

### Claim 50 (depends on 48, 49)

The method defined in claim 48 or 49, wherein bead beating comprises the use of magnetic beads.

### Claim 51 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis comprises using OmniLyse® or a functional equivalent thereof.

### Claim 52 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis comprises use of a French press.

### Claim 53 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis comprises grinding.

### Claim 54 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis comprises shaking.

### Claim 55 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis comprises centrifugation.

### Claim 56 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis comprises a combination of centrifugation and puck lysing.

### Claim 57 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method defined in any one of claims 1-46, wherein the mechanical lysis comprises a combination of centrifugation and magnetic puck lysing.

### Claim 58 (depends on 56, 57)

The method defined in any one of claims 56-57, wherein the combination of centrifugation and puck lysing is carried out in a common lysis chamber.

### Claim 59 (depends on 55, 56, 57, 58)

The method defined in any one of claims 55-58, wherein centrifugation is carried out on a centrifugal disk.

### Claim 60 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59)

The method defined in any one of claims 1-59, wherein Steps (a) and (b) are carried out concurrently.

### Claim 61 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59)

The method defined in any one of claims 1-59, wherein Steps (a) and (b) are carried out sequentially.

### Claim 62 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59)

The method defined in any one of claims 1-59, wherein Step (b) is carried out after commencement of disruption of the cellular membrane in Step (a).

### Claim 63 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The method defined in any one of claims 1-62, wherein the method further comprises neutralizing the sample by contacting the sample with a buffer solution.

### Claim 64 (depends on 63)

The method defined in claim 63, wherein the buffer solution is a phosphate buffer solution.

### Claim 65 (depends on 63, 64)

The method defined in any one of claims 63-64, wherein the buffer solution has a pH of less than 7.

### Claim 66 (depends on 63, 64)

The method defined in any one of claims 63-64, wherein the buffer solution has a pH in the range of from 5 to 7.5.

### Claim 67 (depends on 63, 64)

The method defined in any one of claims 63-64, wherein the buffer solution has a pH in the range of from 6 to 7.

### Claim 68 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67)

The method defined in any one of claims 1-67, comprising the further step of contacting the sample with a nuclease inhibitor.

### Claim 69 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67)

The method defined in any one of claims 1-67, comprising the further step of contacting the sample with a nuclease inhibitor prior to Step (a).

### Claim 70 (depends on 68, 69)

The method defined in any one of claims 68-69, wherein the nuclease inhibitor is an RNAse inhibitor.

### Claim 71 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)

The method defined in any one of claims 1-70, comprising the further step of detecting at least one nucleotide sequence in the cell lysate.

### Claim 72 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)

The method defined in any one of claims 1-70, comprising the further step of detecting at least one nucleotide sequence in the cell lysate using a sandwich assay.

### Claim 73 (depends on 72)

The method defined in claim 72, wherein the sandwich assay is conducted on an electrochemical sensor platform.

### Claim 74 (depends on 71, 72, 73)

The method defined in any one of claims 71-73, wherein the further step of detecting comprises using an electrochemical sensor platform.

### Claim 75 (depends on 71, 72, 73)

The method defined in any one of claims 71-73, wherein the further step of detecting comprises contacting the cell lysate with a capture probe.

### Claim 76 (depends on 71, 72, 73)

The method defined in any one of claims 71-73, wherein the further step of detecting comprises contacting the cell lysate with a magnetic bead.

### Claim 77 (depends on 76)

The method defined in claim 76, wherein the magnetic bead comprises a capture probe.

### Claim 78 (depends on 77)

The method defined in claim 77, wherein the capture probe comprises one or more nucleic acids.

### Claim 79 (depends on 78)

The method defined in claim 78, wherein the one or more nucleic acids comprise one or more deoxyribonucleic acid (DNA).

### Claim 80 (depends on 78)

The method defined in claim 78, wherein the one or more nucleic acids comprise one or more peptide nucleic acids (PNAs).

### Claim 81 (depends on 78)

The method defined in claim 78, wherein the one or more nucleic acids comprise one or more locked nucleic acids (LNAs).

### Claim 82 (depends on 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81)

The method defined in any one of claims 71-81, wherein the further step of detecting comprises contacting the cell lysate with a detector probe.

### Claim 83 (depends on 82)

The method defined in claim 82, wherein the detector probe comprises one or more nucleic acids.

### Claim 84 (depends on 83)

The method defined in claim 83, wherein the one or more nucleic acids comprise one or more deoxyribonucleic acids (DNA).

### Claim 85 (depends on 83)

The method defined in claim 83, wherein the one or more nucleic acids comprise one or more peptide nucleic acids (PNAs).

### Claim 86 (depends on 83)

The method defined in claim 83, wherein the one or more nucleic acids comprise comprises one or more locked nucleic acids (LNAs).

### Claim 87 (depends on 82, 83, 84, 85, 86)

The method defined in any one of claims 82-86, wherein the detector probe comprises a detectable label.

### Claim 88

A method for producing a lysate composition comprising RNA from a sample of mammalian origin comprising a cellular material, the method comprising the steps of:
(a) rotating a microfluidic centrifugal disk comprising a lysis chamber containing the sample;
(b) subjecting the sample to mechanical lysis to cause disruption of a cellular membrane in the cellular material; and
(c) contacting the sample in the lysis chamber with an alkaline solution to produce the lysate composition.

### Claim 89 (depends on 88)

The method defined in claim 88, wherein the RNA is ribosomal RNA (rRNA).

### Claim 90 (depends on 89)

The method defined in claim 89, wherein the rRNA is pre-ribosomal RNA.

### Claim 91 (depends on 89)

The method defined in claim 89, wherein the rRNA is selected from the group consisting of 16S rRNA, 23S rRNA and any mixture thereof.

### Claim 92 (depends on 89)

The method defined in claim 89, wherein the rRNA is mature rRNA.

### Claim 93 (depends on 88, 89, 90, 91, 92)

The method defined in any one of claims 88-92, wherein the alkaline solution comprises a sodium hydroxide solution.

### Claim 94 (depends on 88, 89, 90, 91, 92, 93)

The method defined in any one of claims 88-93, wherein the alkaline solution has a concentration of 10M or less.

### Claim 95 (depends on 88, 89, 90, 91, 92, 93)

The method defined in any one of claims 88-93, wherein the alkaline solution has a concentration in the range of from 1M to 5M.

### Claim 96 (depends on 88, 89, 90, 91, 92, 93)

The method defined in any one of claims 88-93, wherein the alkaline solution has a concentration in the range of from 1.5M to 3M.

### Claim 97 (depends on 88, 89, 90, 91, 92, 93)

The method defined in any one of claims 88-93, wherein the alkaline solution has a concentration of 2M.

### Claim 98 (depends on 88, 89, 90, 91, 92, 93)

The method defined in any one of claims 88-93, wherein the alkaline solution has a concentration of 3M.

### Claim 99 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98)

The method defined in any one of claims 88-98, wherein the sample comprises human cellular material.

### Claim 100 (depends on 99)

The method defined in claim 99, wherein the human cellular material comprises a bodily fluid.

### Claim 101 (depends on 99)

The method defined in claim 99, wherein the human cellular material comprises an inoculant derived from a bodily fluid.

### Claim 102 (depends on 100, 101)

The method defined in claim 100 or 101, wherein the bodily fluid is selected from the group consisting of blood, urine, saliva, sweat, tears, mucus, breast milk, plasma, serum, synovial fluid, pleural fluid, lymph fluid, amniotic fluid, feces, cerebrospinal fluid and any mixture of two or more of these.

### Claim 103 (depends on 99)

The method defined in claim 99, wherein the sample is urine or an inoculant derived therefrom.

### Claim 104 (depends on 99)

The method defined in claim 99, wherein the sample is blood or an inoculant derived therefrom.

### Claim 105 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of 10 minutes or less.

### Claim 106 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of from 30 seconds to 10 minutes.

### Claim 107 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of from 1 minute to 8 minutes.

### Claim 108 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of from 2 minutes±30 seconds.

### Claim 109 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of from 3 minutes±30 seconds.

### Claim 110 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of from 4 minutes±30 seconds.

### Claim 111 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of from 5 minutes±30 seconds.

### Claim 112 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of from 6 minutes±30 seconds.

### Claim 113 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The method defined in any one of claims 88-104, wherein Steps (a) and (b) are conducted for a period of from 7 minutes±30 seconds.

### Claim 114 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114)

The method defined in any one of claims 88-114, wherein Steps (a) and (b) are carried out concurrently.

### Claim 115 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114)

The method defined in any one of claims 88-114, wherein the mechanical lysis comprises a combination of centrifugation and puck lysing.

### Claim 116 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114)

The method defined in any one of claims 88-114, wherein the mechanical lysis comprises a combination of centrifugation and magnetic puck lysing.

### Claim 117 (depends on 115, 116)

The method defined in any one of claims 115-116, wherein the combination of centrifugation and puck lysing is carried out in a common lysis chamber.

### Claim 118 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117)

The method defined in any one of claims 88-117, wherein Steps (b) and (c) are carried out concurrently.

### Claim 119 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117)

The method defined in any one of claims 88-117, wherein Steps (b) and (c) are carried out sequentially.

### Claim 120 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117)

The method defined in any one of claims 88-117, wherein Steps (c) is carried out after commencement of disruption of the cellular membrane in Step (b).

### Claim 121

A method for extracting a nucleic acid from a cellular material in a sample comprising a bodily fluid or an inoculant derived therefrom, the method comprising the steps of:
(a) subjecting the sample to a first lysing process comprising mechanical lysis to cause disruption of a cellular membrane in the cellular material;
(b) subjecting the sample to a second lysing process comprising at least one of physical lysis, chemical lysis, biological lysis and any combination of two or more of these to produce a lysate composition comprising the nucleic acid; and
(c) recovering the lysate composition from the sample.

### Claim 122 (depends on 121)

The method defined in claim 121, wherein the nucleic acid comprises ribosomal RNA (rRNA).

### Claim 123 (depends on 122)

The method defined in claim 122, wherein the rRNA is pre-ribosomal RNA.

### Claim 124 (depends on 122)

The method defined in claim 122, wherein the rRNA is selected from the group consisting of 16S rRNA, 23S rRNA and any mixture thereof.

### Claim 125 (depends on 122)

The method defined in claim 122, wherein the rRNA is mature rRNA.

### Claim 126 (depends on 121, 122, 123, 124, 125)

The method defined in any one of claims 121-125, wherein the chemical lysis comprises contacting the sample with an alkaline solution.

### Claim 127 (depends on 126)

The method defined in claim 126, wherein the alkaline solution comprises a sodium hydroxide solution.

### Claim 128 (depends on 126, 127)

The method defined in any one of claims 126-127, wherein the alkaline solution has a concentration of 10M or less.

### Claim 129 (depends on 126, 127)

The method defined in any one of claims 126-127, wherein the alkaline solution has a concentration in the range of from 1M to 5M.

### Claim 130 (depends on 126, 127)

The method defined in any one of claims 126-127, wherein the alkaline solution has a concentration in the range of from 1.5M to 3M.

### Claim 131 (depends on 126, 127)

The method defined in any one of claims 126-127, wherein the alkaline solution has a concentration of 2M.

### Claim 132 (depends on 126, 127)

The method defined in any one of claims 126-127, wherein the alkaline solution has a concentration of 3M.

### Claim 133 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132)

The method defined in any one of claims 121-132, wherein the sample comprises human cellular material.

### Claim 134 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133)

The method defined in any one of claims 121-133, wherein the sample comprises the bodily fluid.

### Claim 135 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133)

The method defined in any one of claims 121-133, wherein the sample comprises an inoculant of the bodily fluid.

### Claim 136 (depends on 134, 135)

The method defined claim 134 or 135, wherein the bodily fluid is selected from the group consisting of blood, urine, saliva, sweat, tears, mucus, breast milk, plasma, serum, synovial fluid, pleural fluid, lymph fluid, amniotic fluid, feces, cerebrospinal fluid and any mixture of two or more of these.

### Claim 137 (depends on 133)

The method defined in claim 133, wherein the sample is urine or an inoculant derived therefrom.

### Claim 138 (depends on 133)

The method defined in claim 133, wherein the sample is blood or an inoculant derived therefrom.

### Claim 139 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of 10 minutes or less.

### Claim 140 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of from 30 seconds to 10 minutes.

### Claim 141 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of from 1 minute to 8 minutes.

### Claim 142 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of from 2 minutes±30 seconds.

### Claim 143 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of from 3 minutes±30 seconds.

### Claim 144 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of from 4 minutes±30 seconds.

### Claim 145 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of from 5 minutes±30 seconds.

### Claim 146 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of from 6 minutes±30 seconds.

### Claim 147 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein Step (a) is conducted for a period of from 7 minutes±30 seconds.

### Claim 148 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein the mechanical lysis comprises a combination of centrifugation and puck lysing.

### Claim 149 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method defined in any one of claims 121-138, wherein the mechanical lysis comprises a combination of centrifugation and magnetic puck lysing.

### Claim 150 (depends on 148, 149)

The method defined in any one of claims 148-149, wherein the combination of centrifugation and puck lysing is carried out in common lysis chamber.

### Claim 151 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150)

The method defined in any one of claims 121-150, wherein Steps (a) and (b) are carried out concurrently.

### Claim 152 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150)

The method defined in any one of claims 121-150, wherein Steps (a) and (b) are carried out sequentially.

### Claim 153 (depends on 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150)

The method defined in any one of claims 121-150, wherein Step (b) is carried out after commencement of disruption of the cellular membrane in Step (a).
